BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26315324)

  • 21. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
    Ychou M; Rivoire M; Thezenas S; Quenet F; Delpero JR; Rebischung C; Letoublon C; Guimbaud R; Francois E; Ducreux M; Desseigne F; Fabre JM; Assenat E
    Ann Surg Oncol; 2013 Dec; 20(13):4289-97. PubMed ID: 23955585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of perioperative chemotherapy in patients with colorectal cancer undergoing hepatectomy for resectable synchronous liver metastasis.
    Nakanishi M; Kuriu Y; Murayama Y; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Kubota T; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Otsuji E
    Hepatogastroenterology; 2014 Sep; 61(134):1582-7. PubMed ID: 25436346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
    Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
    Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.
    Chiappa A; Bertani E; Makuuchi M; Zbar AP; Contino G; Viale G; Pruneri G; Bellomi M; Della Vigna P; Zampino MG; Fazio N; Travaini ML; Trifirò G; Corbellini C; Andreoni B
    Hepatogastroenterology; 2009; 56(91-92):829-34. PubMed ID: 19621711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
    Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
    Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
    Reddy SK; Zorzi D; Lum YW; Barbas AS; Pawlik TM; Ribero D; Abdalla EK; Choti MA; Kemp C; Vauthey JN; Morse MA; White RR; Clary BM
    Ann Surg Oncol; 2009 Jul; 16(7):1809-19. PubMed ID: 18979139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Analysis between Simultaneous Resection and Staged Resection for Synchronous Colorectal Liver Metastases - A Single Center Experience on 300 Consecutive Patients.
    Alexandrescu S; Diaconescu A; Ionel Z; Zlate C; Grigorie R; Hrehoreţ D; Braşoveanu V; Dima S; Botea F; Ionescu M; Tomescu D; Droc G; Fota R; Croitoru A; Gramaticu I; Buica F; Iacob R; Gheorghe C; Herlea V; Grasu M; Dumitru R; Boroş M; Popescu I
    Chirurgia (Bucur); 2017; 112(3):278-288. PubMed ID: 28675363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the Optimal Timing for Liver Surgery of Resectable Synchronous Liver Metastases from Colorectal Cancer?
    Inoue Y; Imai Y; Osumi W; Shimizu T; Asakuma M; Hirokawa F; Hayashi M; Uchiyama K
    Am Surg; 2017 Jan; 83(1):45-53. PubMed ID: 28234125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.
    Nanji S; Cleary S; Ryan P; Guindi M; Selvarajah S; Al-Ali H; Grieg P; McGilvary I; Taylor B; Wei A; Moulton CA; Gallinger S
    Ann Surg Oncol; 2013 Jan; 20(1):295-304. PubMed ID: 23054102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.
    Hrehoreţ D; Alexandrescu S; Braşoveanu V; Grigorie R; Zielinski C; Popescu I
    Chirurgia (Bucur); 2013; 108(5):719-24. PubMed ID: 24157119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidisciplinary approach of colorectal liver metastases.
    Juez I; Rubio C; Figueras J
    Clin Transl Oncol; 2011 Oct; 13(10):721-7. PubMed ID: 21975333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
    Nagayama S; Hasegawa S; Hida K; Kawada K; Hatano E; Nakamura K; Seo S; Taura K; Yasuchika K; Matsuo T; Zaima M; Kanazawa A; Terajima H; Tada M; Adachi Y; Nishitai R; Manaka D; Yoshimura T; Doi K; Horimatsu T; Mitsuyoshi A; Yoshimura K; Niimi M; Matsumoto S; Sakai Y; Uemoto S
    Int J Clin Oncol; 2017 Apr; 22(2):316-323. PubMed ID: 27752787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.